- Home
- OABI vs WHF Comparison
OABI vs WHF Comparison
Compare OABI & WHF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OABI
- WHF
- Stock Information
- Founded
- OABI 2012
- WHF 2011
- Country
- OABI United States
- WHF United States
- Employees
- OABI N/A
- WHF N/A
- Industry
- OABI Biotechnology: Pharmaceutical Preparations
- WHF Finance Companies
- Sector
- OABI Health Care
- WHF Finance
- Exchange
- OABI Nasdaq
- WHF Nasdaq
- Market Cap
- OABI 228.9M
- WHF 207.1M
- IPO Year
- OABI N/A
- WHF 2012
- Fundamental
- Price
- OABI $1.61
- WHF $8.04
- Analyst Decision
- OABI Strong Buy
- WHF Hold
- Analyst Count
- OABI 3
- WHF 4
- Target Price
- OABI $6.67
- WHF $10.00
- AVG Volume (30 Days)
- OABI 431.3K
- WHF 114.0K
- Earning Date
- OABI 11-11-2025
- WHF 11-06-2025
- Dividend Yield
- OABI N/A
- WHF 22.20%
- EPS Growth
- OABI N/A
- WHF N/A
- EPS
- OABI N/A
- WHF 0.15
- Revenue
- OABI $23,027,000.00
- WHF $81,499,000.00
- Revenue This Year
- OABI N/A
- WHF N/A
- Revenue Next Year
- OABI $44.99
- WHF N/A
- P/E Ratio
- OABI N/A
- WHF $52.54
- Revenue Growth
- OABI 6.05
- WHF N/A
- 52 Week Low
- OABI $1.22
- WHF $8.03
- 52 Week High
- OABI $4.87
- WHF $12.18
- Technical
- Relative Strength Index (RSI)
- OABI 43.00
- WHF 27.87
- Support Level
- OABI $1.54
- WHF $8.70
- Resistance Level
- OABI $1.71
- WHF $8.97
- Average True Range (ATR)
- OABI 0.09
- WHF 0.14
- MACD
- OABI 0.01
- WHF -0.03
- Stochastic Oscillator
- OABI 46.51
- WHF 2.11
About OABI OmniAb Inc.
OmniAb Inc offers therapeutic antibody discovery technologies. It focuses on enabling the rapid development of therapeutics by pushing the frontiers of drug discovery technologies. Its technology platform is designed to enable the efficient discovery of high-quality, fully human antibodies for a wide range of diseases. The heart of the OmniAb technology platform is the Biological Intelligence of its proprietary transgenic animals, including OmniRat, OmniMouse, and OmniChicken, that have been genetically modified to generate antibodies with human sequences which are naturally optimized through in vivo affinity maturation.
About WHF WhiteHorse Finance Inc.
WhiteHorse Finance Inc is a non-diversified, closed-end management investment company. It makes debt investments in privately held; small-cap companies located in United States. Its investment objective is to generate risk-adjusted returns by originating and investing in senior secured loans, including first lien and second lien facilities, to performing lower middle market companies across a range of industries.